The specific division of the U.S. Department of Justice that fought Anthem’s $54 billion acquisition of Cigna—and which the insurers is still pushing to approve the merger over antitrust concerns—could be run by a former Anthem lobbyist.

Mayo Clinic is being reviewed by the Minnesota Department of Human Services (DHS) for possibly breaking civil and human rights laws after comments from CEO John Noseworthy, MD, encouraging employees to prioritize commercially insured patients over Medicare and Medicaid beneficiaries.

The Medical Group Management Association (MGMA) has asked newly confirmed CMS Administrator Seema Verma to quickly release overdue eligibility information for the Merit-based Incentive Payment System (MIPS), one of two new payment tracks implemented as part of the Medicare Access and CHIP Reauthorization Act (MACRA). 

It’s the job of Sen. Dick Durbin, D-Illinois, as the Senate minority whip to know where every member of his caucus stands on major pieces of legislation. When it comes to the American Health Care Act (AHCA), the Republican-sponsored plan to repeal and replace the Affordable Care Act (ACA), he said to HealthExec “no” Democrats in the chamber would support the bill as-is.

Spending on Medicare Part D subscribers was $345 lower per patient when that beneficiary was aligned with an accountable care organization (ACO), according to an analysis from the University of Pittsburgh School of Public Health.

Included in President Donald Trump’s budget proposal for fiscal year 2018 is a big increase in what the medical device and pharmaceutical industries would pay the Food and Drug Administration (FDA) to cover the costs of reviewing their products.

President Donald Trump’s budget proposal for 2018 would reduce funding to HHS by $15.1 billion, a cut of nearly 18 percent, eliminating millions for education and training programs for healthcare professionals, while cutting $5.8 billion from the National Institutes of Health (NIH) alone.

Diagnosing cancer involves physicians reviewing large amounts of data. Still, variability among pathologists can complicate the process and result in misdiagnoses. Google is hoping to use deep learning to develop an algorithm capable of detecting cancer.